Free Trial

Evoke (LON:EVOK) Stock Price Down 10% - Should You Sell?

Evoke logo with Consumer Cyclical background
Remove Ads

Evoke plc (LON:EVOK - Get Free Report) shares dropped 10% during trading on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares changed hands during mid-day trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).

Wall Street Analyst Weigh In

EVOK has been the subject of a number of research analyst reports. Berenberg Bank reduced their target price on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a "buy" rating for the company in a research note on Wednesday, December 4th. Jefferies Financial Group reaffirmed a "buy" rating and set a GBX 140 ($1.81) price target on shares of Evoke in a research report on Monday, December 16th.

Check Out Our Latest Stock Report on Evoke

Evoke Price Performance

The business has a 50-day simple moving average of GBX 68.36 and a two-hundred day simple moving average of GBX 63.39. The stock has a market cap of £211.75 million, a price-to-earnings ratio of -1.19 and a beta of 0.84.

Evoke (LON:EVOK - Get Free Report) last posted its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. As a group, equities analysts anticipate that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.

Insider Buying and Selling at Evoke

In other news, insider Andrea Gisle Joosen acquired 14,572 shares of Evoke stock in a transaction dated Tuesday, January 28th. The stock was bought at an average price of GBX 70 ($0.90) per share, for a total transaction of £10,200.40 ($13,178.81). Corporate insiders own 27.00% of the company's stock.

About Evoke

(Get Free Report)

Read More

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads